Keyphrases
Left Ventricular Dysfunction
100%
Infarction
100%
Cardiac Progenitor Cells
100%
Intracoronary Administration
100%
Old Myocardial Infarction
26%
Left Ventricular Function
13%
Reperfusion
13%
Acute Myocardial Infarction
13%
Enhanced Green Fluorescent Protein (eGFP)
13%
Intracoronary Infusion
13%
Transplantation
6%
Clinically Significant
6%
Fibrosis
6%
Therapeutic Approaches
6%
Structural Effect
6%
New Therapeutics
6%
Risk Areas
6%
Cardiomyocytes
6%
Vascular Smooth muscle Cells
6%
Paracrine Effect
6%
Therapeutic Use
6%
Functional Impact
6%
Cardiac Cells
6%
Cell Markers
6%
Coronary Occlusion
6%
Viable Myocardium
6%
Myocardial Scar
6%
Chronic Ischemic Cardiomyopathy
6%
Cardiac Proteins
6%
Medicine and Dentistry
Infarction
100%
Heart Left Ventricle Failure
100%
Progenitor Cell
100%
Intracoronary Drug Administration
100%
Myocardial Infarction
26%
Heart Left Ventricle Function
13%
Enhanced Green Fluorescent Protein
13%
Acute Heart Infarction
13%
Fibrosis
6%
Myocardium
6%
Cardiac Muscle Cell
6%
Vascular Smooth Muscle Cell
6%
Coronary Occlusion
6%
Cell Marker
6%
Ischemic Cardiomyopathy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Infarction
100%
Heart Left Ventricle Failure
100%
Acute Heart Infarction
50%
Enhanced Green Fluorescent Protein
50%
Fibrosis
25%
Cell Marker
25%
Coronary Artery Occlusion
25%
Ischemic Cardiomyopathy
25%
Biochemistry, Genetics and Molecular Biology
Progenitor Cell
100%
Heart Ventricle Function
100%
Green Fluorescent Protein
13%
Reperfusion
13%
Heart Left Ventricle Function
13%
Cardiac Muscle Cell
6%
Cell Marker
6%